Show simple item record

dc.contributor.authorTaylor, Mckenzie
dc.contributor.authorTran, Stephanie
dc.date2022-08-11T08:08:07.000
dc.date.accessioned2022-08-23T15:43:06Z
dc.date.available2022-08-23T15:43:06Z
dc.date.issued2019-04-10
dc.date.submitted2019-07-31
dc.identifier.doi10.13028/dc3p-8349
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27011
dc.description<p>Blog post to Commonwealth Medicine's website - <a href="https://commed.umassmed.edu/blog/2019/04/10/will-ending-certain-drug-rebates-lower-list-prices-and-patient-out-pocket-costs" target="_blank">view blog post online</a></p>
dc.description.abstractEarlier this year, the Department of Health and Human Services (HHS) proposed changes to the current pricing and contracting system for federal health care programs, Medicare Part D and Medicaid.This proposal aligns with the Trump Administration’s blueprint for lowering drug prices which we have written about previously.
dc.language.isoen_US
dc.rights© 2019 University of Massachusetts Medical School
dc.subjectprescription drug rebates
dc.subjectlist prices
dc.subjectpatients
dc.subjectout-of-pocket costs
dc.subjectdrug companies
dc.subjectpharmacy benefit managers
dc.subjectHealth Economics
dc.subjectHealth Law and Policy
dc.subjectHealth Policy
dc.subjectHealth Services Administration
dc.subjectHealth Services Research
dc.subjectPharmacy Administration, Policy and Regulation
dc.titleWill ending certain drug rebates lower list prices and patient out-of-pocket costs?
dc.typeBlog Post
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1235&amp;context=commed_pubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/commed_pubs/237
dc.identifier.contextkey15028679
refterms.dateFOA2022-08-23T15:43:07Z
html.description.abstract<p>Earlier this year, the Department of Health and Human Services (HHS) proposed changes to the current pricing and contracting system for federal health care programs, Medicare Part D and Medicaid.This proposal aligns with the Trump Administration’s blueprint for lowering drug prices which we have written about previously.</p>
dc.identifier.submissionpathcommed_pubs/237
dc.contributor.departmentCommonwealth Medicine, Clinical Pharmacy Services


Files in this item

Thumbnail
Name:
wiiilll.pdf
Size:
498.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record